AU2003267656A1 - Process and intermediates for the preparation of thienopyrrole derivatives - Google Patents

Process and intermediates for the preparation of thienopyrrole derivatives Download PDF

Info

Publication number
AU2003267656A1
AU2003267656A1 AU2003267656A AU2003267656A AU2003267656A1 AU 2003267656 A1 AU2003267656 A1 AU 2003267656A1 AU 2003267656 A AU2003267656 A AU 2003267656A AU 2003267656 A AU2003267656 A AU 2003267656A AU 2003267656 A1 AU2003267656 A1 AU 2003267656A1
Authority
AU
Australia
Prior art keywords
alkyl
formula
carbamoyl
amino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267656A
Other languages
English (en)
Inventor
Michael Butters
Paul Schofield
Andrew Stocker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003267656A1 publication Critical patent/AU2003267656A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AU2003267656A 2002-10-03 2003-09-29 Process and intermediates for the preparation of thienopyrrole derivatives Abandoned AU2003267656A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0222909.4A GB0222909D0 (en) 2002-10-03 2002-10-03 Novel process and intermediates
GB0222909.4 2002-10-03
PCT/GB2003/004211 WO2004031193A1 (en) 2002-10-03 2003-09-29 Process and intermediates for the preparation of thienopyrrole derivatives

Publications (1)

Publication Number Publication Date
AU2003267656A1 true AU2003267656A1 (en) 2004-04-23

Family

ID=9945217

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267656A Abandoned AU2003267656A1 (en) 2002-10-03 2003-09-29 Process and intermediates for the preparation of thienopyrrole derivatives

Country Status (13)

Country Link
US (1) US7307174B2 (enExample)
EP (1) EP1549653A1 (enExample)
JP (1) JP2006503077A (enExample)
KR (1) KR20050061490A (enExample)
CN (1) CN1688588A (enExample)
AU (1) AU2003267656A1 (enExample)
BR (1) BR0314312A (enExample)
CA (1) CA2498843A1 (enExample)
GB (1) GB0222909D0 (enExample)
MX (1) MXPA05003387A (enExample)
NO (1) NO20051047L (enExample)
WO (1) WO2004031193A1 (enExample)
ZA (1) ZA200501742B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0321003D0 (en) * 2003-09-09 2003-10-08 Angeletti P Ist Richerche Bio Compounds, compositions and uses
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
MX2009007395A (es) * 2007-01-09 2009-07-17 Bayer Schering Pharma Ag Marcacion radioactiva por fluoracion de aziridinas.
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
CN106588868A (zh) * 2016-11-16 2017-04-26 武汉理工大学 一种2‑溴‑3‑噻吩甲酸中间体的合成方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU364613A1 (ru) 1970-11-27 1972-12-28 Всесоюзный научно исследовательский химико фармацевтический институт имени С. Орджоникидзе Способ получения производных 2-аминотиено-
GB9302622D0 (en) * 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
PT1088824E (pt) 1999-09-30 2004-04-30 Pfizer Prod Inc Pirrolil-amidas biciclicas como inibidores de glicogenio-fosforilase
AU778042B2 (en) 1999-10-19 2004-11-11 Merck & Co., Inc. Tyrosine kinase inhibitors
SE9903998D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
JP2001294572A (ja) 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
GB0017676D0 (en) * 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
GB0021831D0 (en) 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
MXPA03000966A (es) 2002-02-28 2003-09-04 Pfizer Prod Inc Agentes antidiabeticos.
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
AU2003227360A1 (en) 2002-04-25 2003-11-10 Yamanouchi Pharmaceutical Co., Ltd. Novel amide derivatives or salts thereof
AU2003272285A1 (en) * 2002-09-06 2004-03-29 Janssen Pharmaceutica, N.V. Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
AU2003274462A1 (en) 2002-11-07 2004-06-07 Pfizer Products Inc. N-(indole-2-carbonyl) amides as anti-diabetic agents
US7098235B2 (en) * 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
JP2004196702A (ja) 2002-12-18 2004-07-15 Yamanouchi Pharmaceut Co Ltd 新規なアミド誘導体又はその塩
KR20050110612A (ko) 2002-12-25 2005-11-23 다이이찌 세이야꾸 가부시기가이샤 디아민 유도체
CA2522225A1 (en) 2003-04-17 2004-10-28 Pfizer Products Inc. Carboxamide derivatives as anti-diabetic agents
WO2004096768A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Anti-diabetic agents
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
GB0318464D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
WO2005020985A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
CN1688588A (zh) 2005-10-26
GB0222909D0 (en) 2002-11-13
CA2498843A1 (en) 2004-04-15
ZA200501742B (en) 2006-03-29
MXPA05003387A (es) 2005-06-22
JP2006503077A (ja) 2006-01-26
US7307174B2 (en) 2007-12-11
KR20050061490A (ko) 2005-06-22
EP1549653A1 (en) 2005-07-06
US20050272938A1 (en) 2005-12-08
WO2004031193A1 (en) 2004-04-15
NO20051047L (no) 2005-04-28
BR0314312A (pt) 2005-07-26

Similar Documents

Publication Publication Date Title
EP1549653A1 (en) Process and intermediates for the preparation of thienopyrrole derivatives
JP6188960B2 (ja) ブレクスピプラゾール、重要な中間体およびその塩の製造方法
SK12582001A3 (sk) 4-Oxo-4,7-dihydro-tieno[2,3-b] pyridín-5-karboxamidy ako antivírusové prostriedky, spôsob ich prípravy, medziprodukty a farmaceutická kompozícia
AU2003269219A1 (en) Process and intermediates for the preparation of the thienopyrrole derivatives
SU1217260A3 (ru) Способ получени 6-хлор/или бром/-1,2-дигидро-3 @ -пирроло/1,2- @ / пиррол-1-карбоновых кислот или их фармацевтически приемлемых солей
WO2010103115A1 (en) Process for preparing brinzolamide
AU2004249697B2 (en) Thiazoline derivatives as selective androgen receptor modulators (SARMS)
JPS6210087A (ja) ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤
CA1341159C (en) Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use
MXPA04005863A (es) Compuestos inhibidores de lipasa pancreatica, su sintesis y uso.
JP2003507453A (ja) ライノウイルスプロテアーゼ・インヒビター及び鍵中間体の調製の為の合成経路
TW200913995A (en) Process for the preparation of benzimidazol thienylamine compounds and derivatives thereof useful as sodium/proton exchanger type 3 inhibitors
CN101723954B (zh) 一种制备奥氮平的工艺
EP0025643A1 (en) Oxo-pyrido(1,2-a)thienopyrimidine compounds, processes for their production, and pharmaceutical compositions containing said compounds
CN116874412A (zh) 一种芬太尼类似物的合成方法
CN105439933B (zh) 一种培南类药物硫醇支链的制备方法
JP2000309591A (ja) ジヒドロベンズ［ｃ］チオフェン化合物
KR20020068140A (ko) [(2-옥소-3-테트라히드로티에닐카바모일)-메틸티오]아세트산의 제조방법
CN113861075A (zh) 一种具有连续三个手性中心的手性双烯丙基取代化合物及其制备方法与应用
JP2000501091A (ja) キラルな３―ヒドロキシ―２―ピロリジノン誘導体の製造方法
EP0480692A2 (en) Substituted 4,5-dihydrothieno[2,3-b]thiophene-2-sulfonamides
RS20050543A (sr) Postupak i intermedijati za dobijanje olanzapina
Chihaba et al. Development of New Experimental NMR Strategy of Cysteine Protease Inhibitors Screening: Toward Enhanced Drug Discovery
MXPA00009418A (en) PYRROLO[1,2-a]PYRAZINE sPLA2
HU224963B1 (en) Oxazolidinone compounds and process for the preparation thereof

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted